Сравнение методов

	Шкала ходьбы при рассеянном склерозе-12 (MSWS-12)	Шкала качества жизни при рассеянном склерозе-54 (MSQOL-54)	Шкала качества жизни, специфичная для инсульта (SS-QoL)
Область	Неврология	Неврология	Неврология
Семейство	Process / pipeline	Process / pipeline	Process / pipeline
Год появления	2003	1995	1999
Автор метода	Jeremy C. Hobart, University of Plymouth	Barbara G. Vickrey, UCLA	Lee S. Williams, Indiana University
Тип	Self-report questionnaire	Self-report questionnaire	Self-report questionnaire
Основополагающий источник	Hobart, J. C., Riazi, A., Lamping, D. L., Fitzpatrick, R., & Thompson, A. J. (2003). Measuring the impact of MS on walking ability: The 12-Item MS Walking Scale (MSWS-12). Neurology, 60(1), 31-36.	Vickrey, B. G., Hays, R. D., Genovese, B. J., Myers, L. W., & Ellison, G. W. (1995). Outcomes in Multiple Sclerosis: The Multiple Sclerosis Quality of Life-54 Scale. Health Psychology, 14(1), 34-42.	Williams, L. S., Weinberger, M., Harris, L. E., Clark, D. O., & Biller, J. (1999). Development of a Stroke-Specific Quality of Life Scale. Stroke, 30(7), 1362-1369.
Другие названия	MS Walking Scale-12, MSWS	MS QoL-54	Stroke-Specific QoL, SS-QOL
Связанные	3	4	4
Сводка	The MSWS-12 is a brief, patient-reported outcome measure specifically designed to assess the impact of multiple sclerosis on walking ability and limitation. Developed by Hobart and colleagues in 2003, this 12-item scale captures both the physical difficulty and functional consequences of MS-related gait impairment. It is highly responsive to change and widely used in MS clinical trials and practice as a primary outcome measure for assessing intervention effects on mobility.	The MSQOL-54 is a disease-specific quality-of-life instrument designed to assess the physical and mental burden of multiple sclerosis on patients' daily functioning and well-being. Developed by Vickrey and colleagues in 1995, it combines the widely-used SF-36 generic health questionnaire with 18 MS-specific items to provide comprehensive measurement of QoL in MS populations. This scale is a cornerstone tool in MS clinical research and patient monitoring.	The SS-QoL is a disease-specific quality-of-life instrument designed to capture the multidimensional impact of stroke on survivors' functional and emotional well-being. Developed by Williams and colleagues in 1999, this 49-item scale addresses stroke-specific concerns including language, cognition, mobility, and emotional functioning. It is a gold-standard instrument for stroke outcome research and routine clinical monitoring of post-stroke recovery.